News & Press: General News

FY16 CCTS Conference Letter

Thursday, November 19, 2015  
Share |

FY16 CCTS CONFERENCE LETTER
November 9, 2015

Dear Chairmen Blunt and Cole, and Ranking Members Murray and DeLauro:
 
Thank you for your continued leadership on public health issues and your continuing support for the full spectrum of medical research. As you work to finalize appropriations for fiscal year (FY) 2016 the clinical and translational research community encourages you to adopt the following allocations for critical programs and activities.

  • At least $32 billion for the National Institutes of Health (NIH), consistent with the recommendation included within the Senate’s FY 2016 Labor-Health and Human Services-Education (LHHS) Appropriations Bill.
  • At least $2.51 billion for the National Institute of General Medical Sciences (NIGMS) at NIH, consistent with the recommendation included within the Senate’s FY 2016 LHHS Appropriations Bill.
  • At least $312 million of the Institutional Development Awards Program (IDeA) at NIGMS, consistent with the recommendation included within the House’s FY 2016 LHHS Appropriations Bill.
  • At least $699.32 million for the National Center for Advancing Translational Sciences (NCATS) at NIH, consistent with the recommendation included within the Senate FY16 LHHS Appropriations Bill.
  • At least $499.75 million for the Clinical and Translational Science Awards (CTSA) program at NCATS, consistent with the recommendation included within the Senate’s FY 2016 LHHS Appropriations Bill.
  • At least $287.38 million for the National Institute on Minority Health and Health Disparities (NIMHD) at NIH, consistent with the recommendation included within the Senate’s FY 2016 LHHS Appropriations Bill.
  • At least $58.66 million for the Research Centers at Minority Institutions (RCMI) program at NIMHD, consistent with the recommendation included within the House’s FY 2016 LHHS Appropriations Bill. 
  • Please restore funding to the Agency for Healthcare Research and Health Quality (AHRQ) to FY 2015 enacted levels so that the AHRQ can continue to advance its unique and important mission.
 
The Coalition for Clinical and Translational Science (CCTS) is the unified voice of the clinical and translational research community. We act as a nationwide, grassroots network of scientists and academic and healthcare leaders who work together to educate Congress and the administration about the value and importance of federal clinical and translational research and of research training and career development activities. CCTS’s goals are to ensure that the full spectrum of medical research is adequately funded, translating from the bench, to the bedside, to practice, to public benefit and policy, with real impact on health. We join the nation in believing that the ultimate goal of the “H” in “NIH” is that there should be a focus on health. To serve that, we believe that the NIH must support the full spectrum of such research and must ensure that the next generation of researchers is well-prepared. We also support a regulatory and public policy environment facilitates ongoing expansion and advancement of the field of clinical and translational science.
 
Thank you for your time and your consideration of these priorities as you work with your colleagues to finalize appropriations for FY 2106.
 
Sincerely,
 
 
Rebecca D. Jackson, MD                                                        Herb Pardes, MD
President                                                                                    Vice Chair     
Association for Clinical and Translational Science            The Clinical Research Forum

Harry Selker, M.D., MSPH                           
Chair
The Clinical Research Forum
President-Elect
Association for Clinical and Translational Science